4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000006
Chief Medical Officer sold 621 shares at $50.02 ($31,063)
- Chief Medical Officer acquired 621 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bowden Christopher · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-11 | Exercise or conversion : show line 1 in the form | +621 | $35.16 | $21,834 | 2,271 | D |
| 2020-02-11 | Sale : show line 2 in the form | −621 | $50.02 | $31,063 | 1,650 | D |
| Open-market sales · 621 sh · avg $50.02 · $31,063 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-11 | Exercise or conversion : show line 3 in the form Stock option (right to buy) | −621 | 26,406 | D |
Loading xslF345X03/wf-form4_158162886617100.xml…